2024

Heggie, R., Jaiswal, N. , McCartney, E. , Moss, J., Menne, T., Jones, B., Boyd, K. , Soulis, E., Hawkins, N. and Wu, O. (2024) Central venous access devices for the delivery of systemic anticancer therapy: an economic evaluation. Value in Health, 27(1), pp. 7-14. (doi: 10.1016/j.jval.2023.09.2996) (PMID:37844662)

2022

Helmstetter, N. et al. (2022) Population genetics and microevolution of clinical Candida glabrata reveals recombinant sequence types and hyper-variation within mitochondrial genomes, virulence genes and drug-targets. Genetics, 221(1), iyac031. (doi: 10.1093/genetics/iyac031) (PMID:35199143)

2021

Moss, J. G. et al. (2021) Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial. Lancet, 398(10298), pp. 403-415. (doi: 10.1016/S0140-6736(21)00766-2) (PMID:34297997)

Wu, O. et al. (2021) Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT. Health Technology Assessment, 25(47), (doi: 10.3310/hta25470)

2018

Delpech, P., ALeryan, M., Jones, B., Gemmell, C. and Lang, S. (2018) An in vitro evaluation of the efficacy of tedizolid: implications for the treatment of skin and soft tissue infections. Diagnostic Microbiology and Infectious Disease, 91(1), pp. 93-97. (doi: 10.1016/j.diagmicrobio.2018.01.006) (PMID:29452993)

2017

Jones, B. L., Richardson, M. D., Ingram, P. M. and Agrawal, S. G. (2017) A CONSORT analysis of randomised controlled trials for the treatment of invasive aspergillosis. Medical Mycology, 55(6), pp. 605-613. (doi: 10.1093/mmy/myw133) (PMID:27915306)

2016

Rajendran, R. et al. (2016) Integrating Candida albicans metabolism with biofilm heterogeneity by transcriptome mapping. Scientific Reports, 6, 35436. (doi: 10.1038/srep35436) (PMID:27765942) (PMCID:PMC5073228)

Rajendran, R., Sherry, L. , Ashutosh, D., Johnson, E. M., Hanson, M. F., Williams, C., Munro, C., Jones, B. L. and Ramage, G. (2016) A prospective surveillance study of candidaemia: Epidemiology, risk factors, antifungal treatment and outcome in hospitalised patients. Frontiers in Microbiology, 7, 915. (doi: 10.3389/fmicb.2016.00915) (PMID:27379047) (PMCID:PMC4910670)

Rajendran, R., Sherry, L. , Nile, C. , Sherriff, A. , Johnson, E., Hanson, M., Williams, C., Munro, C., Jones, B. and Ramage, G. (2016) Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection – Scotland, 2012-2013. Clinical Microbiology and Infection, 22(1), pp. 87-93. (doi: 10.1016/j.cmi.2015.09.018) (PMID:26432192)

2015

Rajendran, R., Mowat, E., Jones, B., Williams, C. and Ramage, G. (2015) Prior in vitro exposure to voriconazole confers resistance to amphotericin B in aspergillus fumigatus biofilms. International Journal of Antimicrobial Agents, 46(3), pp. 342-345. (doi: 10.1016/j.ijantimicag.2015.03.006) (PMID:25979638)

2014

Cordina, C. J., Culleton, R., Jones, B. L., Smith, C. C., MacConnachie, A. A., Coyne, M. J. and Alexander, C. L. (2014) Plasmodium knowlesi: clinical presentation and laboratory diagnosis of the first human case in a Scottish traveler. Journal of Travel Medicine, 21(5), pp. 357-360. (doi: 10.1111/jtm.12131) (PMID:24861374)

Sherry, L. et al. (2014) Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity. BMC Microbiology, 14(1), p. 182. (doi: 10.1186/1471-2180-14-182)

2013

Ramage, G. , Jose, A., Sherry, L. , Lappin, D. F., Jones, B. and Williams, C. (2013) Liposomal amphotericin B displays rapid dose-dependent activity against candida albicans biofilms. Antimicrobial Agents and Chemotherapy, 57(5), pp. 2369-2371. (doi: 10.1128/AAC.02344-12)

2012

Agrawal, S. et al. (2012) A practical critique of antifungal treatment guidelines for haemato-oncologists. Critical Reviews in Microbiology, 38(3), pp. 203-216. (doi: 10.3109/1040841X.2011.645521)

Marek, A., McColl, K., Going, J., Spence, G., Jones, B. and Alexander, C. (2012) What a professor learned about Cyclospora cayetanensis by attending Digestive Diseases Week Conference in Chicago. American Journal of Gastroenterology, 107(7), pp. 1109-1111. (doi: 10.1038/ajg.2012.74)

2011

Ramage, G. , Rajendran, R., Gutierrez-Correa, M., Jones, B. and Williams, C. (2011) Aspergillus biofilms: clinical and industrial significance. FEMS Microbiology Letters, 324(2), pp. 89-97. (doi: 10.1111/j.1574-6968.2011.02381.x)

Cornely, O.A., Aversa, F., Cook, P., Jones, B., Michallet, M., Shea, T. and Vallejo, C. (2011) Evaluating the role of prophylaxis in the management of invasive fungal infections in patients with hematologic malignancy. European Journal of Haematology, 87(4), pp. 289-301. (doi: 10.1111/j.1600-0609.2011.01682.x)

2010

Ramage, G. , Culshaw, S. , Jones, B. and Williams, C. (2010) Are we any closer to beating the biofilm: novel methods of biofilm control. Current Opinion in Infectious Diseases, 23(6), pp. 560-566. (doi: 10.1097/QCO.0b013e32833e5850) (PMID:20717027)

Articles

Heggie, R., Jaiswal, N. , McCartney, E. , Moss, J., Menne, T., Jones, B., Boyd, K. , Soulis, E., Hawkins, N. and Wu, O. (2024) Central venous access devices for the delivery of systemic anticancer therapy: an economic evaluation. Value in Health, 27(1), pp. 7-14. (doi: 10.1016/j.jval.2023.09.2996) (PMID:37844662)

Helmstetter, N. et al. (2022) Population genetics and microevolution of clinical Candida glabrata reveals recombinant sequence types and hyper-variation within mitochondrial genomes, virulence genes and drug-targets. Genetics, 221(1), iyac031. (doi: 10.1093/genetics/iyac031) (PMID:35199143)

Moss, J. G. et al. (2021) Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial. Lancet, 398(10298), pp. 403-415. (doi: 10.1016/S0140-6736(21)00766-2) (PMID:34297997)

Wu, O. et al. (2021) Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT. Health Technology Assessment, 25(47), (doi: 10.3310/hta25470)

Delpech, P., ALeryan, M., Jones, B., Gemmell, C. and Lang, S. (2018) An in vitro evaluation of the efficacy of tedizolid: implications for the treatment of skin and soft tissue infections. Diagnostic Microbiology and Infectious Disease, 91(1), pp. 93-97. (doi: 10.1016/j.diagmicrobio.2018.01.006) (PMID:29452993)

Jones, B. L., Richardson, M. D., Ingram, P. M. and Agrawal, S. G. (2017) A CONSORT analysis of randomised controlled trials for the treatment of invasive aspergillosis. Medical Mycology, 55(6), pp. 605-613. (doi: 10.1093/mmy/myw133) (PMID:27915306)

Rajendran, R. et al. (2016) Integrating Candida albicans metabolism with biofilm heterogeneity by transcriptome mapping. Scientific Reports, 6, 35436. (doi: 10.1038/srep35436) (PMID:27765942) (PMCID:PMC5073228)

Rajendran, R., Sherry, L. , Ashutosh, D., Johnson, E. M., Hanson, M. F., Williams, C., Munro, C., Jones, B. L. and Ramage, G. (2016) A prospective surveillance study of candidaemia: Epidemiology, risk factors, antifungal treatment and outcome in hospitalised patients. Frontiers in Microbiology, 7, 915. (doi: 10.3389/fmicb.2016.00915) (PMID:27379047) (PMCID:PMC4910670)

Rajendran, R., Sherry, L. , Nile, C. , Sherriff, A. , Johnson, E., Hanson, M., Williams, C., Munro, C., Jones, B. and Ramage, G. (2016) Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection – Scotland, 2012-2013. Clinical Microbiology and Infection, 22(1), pp. 87-93. (doi: 10.1016/j.cmi.2015.09.018) (PMID:26432192)

Rajendran, R., Mowat, E., Jones, B., Williams, C. and Ramage, G. (2015) Prior in vitro exposure to voriconazole confers resistance to amphotericin B in aspergillus fumigatus biofilms. International Journal of Antimicrobial Agents, 46(3), pp. 342-345. (doi: 10.1016/j.ijantimicag.2015.03.006) (PMID:25979638)

Cordina, C. J., Culleton, R., Jones, B. L., Smith, C. C., MacConnachie, A. A., Coyne, M. J. and Alexander, C. L. (2014) Plasmodium knowlesi: clinical presentation and laboratory diagnosis of the first human case in a Scottish traveler. Journal of Travel Medicine, 21(5), pp. 357-360. (doi: 10.1111/jtm.12131) (PMID:24861374)

Sherry, L. et al. (2014) Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity. BMC Microbiology, 14(1), p. 182. (doi: 10.1186/1471-2180-14-182)

Ramage, G. , Jose, A., Sherry, L. , Lappin, D. F., Jones, B. and Williams, C. (2013) Liposomal amphotericin B displays rapid dose-dependent activity against candida albicans biofilms. Antimicrobial Agents and Chemotherapy, 57(5), pp. 2369-2371. (doi: 10.1128/AAC.02344-12)

Agrawal, S. et al. (2012) A practical critique of antifungal treatment guidelines for haemato-oncologists. Critical Reviews in Microbiology, 38(3), pp. 203-216. (doi: 10.3109/1040841X.2011.645521)

Marek, A., McColl, K., Going, J., Spence, G., Jones, B. and Alexander, C. (2012) What a professor learned about Cyclospora cayetanensis by attending Digestive Diseases Week Conference in Chicago. American Journal of Gastroenterology, 107(7), pp. 1109-1111. (doi: 10.1038/ajg.2012.74)

Ramage, G. , Rajendran, R., Gutierrez-Correa, M., Jones, B. and Williams, C. (2011) Aspergillus biofilms: clinical and industrial significance. FEMS Microbiology Letters, 324(2), pp. 89-97. (doi: 10.1111/j.1574-6968.2011.02381.x)

Cornely, O.A., Aversa, F., Cook, P., Jones, B., Michallet, M., Shea, T. and Vallejo, C. (2011) Evaluating the role of prophylaxis in the management of invasive fungal infections in patients with hematologic malignancy. European Journal of Haematology, 87(4), pp. 289-301. (doi: 10.1111/j.1600-0609.2011.01682.x)

Ramage, G. , Culshaw, S. , Jones, B. and Williams, C. (2010) Are we any closer to beating the biofilm: novel methods of biofilm control. Current Opinion in Infectious Diseases, 23(6), pp. 560-566. (doi: 10.1097/QCO.0b013e32833e5850) (PMID:20717027)